{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:37:05Z","timestamp":1782517025317,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001424","name":"American Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.euo.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T16:26:00Z","timestamp":1560011160000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study\/SPCG11"],"prefix":"10.1016","volume":"4","author":[{"given":"Mariana","family":"Reza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuvo","family":"Tammela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Cicalese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Gomez","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tubaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Debruyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christien","family":"Caris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Thorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Wollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edenbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Tr\u00e4g\u00e5rdh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bjartell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2019.05.002_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eururo.2014.01.020","article-title":"Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study","volume":"67","author":"Joniau","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2019.05.002_bib0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.eururo.2014.02.014","article-title":"Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS)","volume":"67","author":"Wirth","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2019.05.002_bib0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2015.06.039","article-title":"Metastatic prostate cancer and the bone: significance and therapeutic options","volume":"68","author":"Gartrell","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2019.05.002_bib0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2012.01.037","article-title":"A automated platform for quantifying the extent of skeletal tumor involvement in prostate cancer patients using Bone Scan Index","volume":"62","author":"Ulmert","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2019.05.002_bib0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/2191-219X-3-64","article-title":"Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of Bone Scan Index","volume":"3","author":"Kaboteh","year":"2013","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euo.2019.05.002_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2967\/jnumed.115.160085","article-title":"Analytical validation of the automated Bone Scan Index as an imaging biomarker to standardize the quantitative changes in bone scans of patients with metastatic prostate cancer","volume":"57","author":"Anand","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2019.05.002_bib0140","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2967\/jnumed.116.177030","article-title":"A pre-analytical validation study of automated Bone Scan Index: effect on accuracy and reproducibility due to the procedural variabilities in bone scan image acquisition","volume":"57","author":"Anand","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2019.05.002_bib0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12885-016-2160-1","article-title":"Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer","volume":"16","author":"Uemura","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2019.05.002_bib0150","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.euf.2016.02.013","article-title":"Bone Scan Index as an imaging biomarker in metastatic castration-resistant prostate cancer: a multicenter study based on patients treated with abiraterone acetate (Zytiga) in clinical practice","volume":"2","author":"Reza","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2019.05.002_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13550-016-0173-z","article-title":"Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide","volume":"6","author":"Anand","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euo.2019.05.002_bib0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.euf.2016.01.005","article-title":"Bone Scan Index and progression-free survival data for progressive metastatic castration-resistant prostate cancer patients who received ODM-201 in the ARADES multicentre study","volume":"2","author":"Reza","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2019.05.002_bib0165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.urolonc.2014.08.006","article-title":"Assessment of the Bone Scan Index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)","volume":"32","author":"Armstrong","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2019.05.002_bib0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13550-014-0058-y","article-title":"Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy","volume":"4","author":"Reza","year":"2014","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euo.2019.05.002_bib0175","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2014.55.3875","article-title":"Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results","volume":"33","author":"Morris","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2019.05.002_bib0180","first-page":"BP99","article-title":"Bone scintigraphy: procedure guidelines for tumour imaging","volume":"30","author":"Bombardieri","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2019.05.002_bib0185","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/bioinformatics\/btr511","article-title":"Survcomp: an R\/Bioconductor package for performance assessment and comparison of survival models","volume":"27","author":"Schroeder","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.euo.2019.05.002_bib0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2191-219X-3-9","article-title":"Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy","volume":"3","author":"Kaboteh","year":"2013","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euo.2019.05.002_bib0195","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamaoncol.2018.1093","article-title":"Phase 3 assessment of the automated Bone Scan Index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer: a secondary analysis of a randomized clinical trial","volume":"4","author":"Armstrong","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2019.05.002_bib0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2014.10.001","article-title":"Bone-related parameters are the main prognostic factors for overall survival in men with bone metastases from castration-resistant prostate cancer","volume":"68","author":"Fizazi","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2019.05.002_bib0205","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1016\/S1470-2045(18)30604-1","article-title":"Consensus on molecular imaging and theranostics in prostate cancer","volume":"19","author":"Fanti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2019.05.002_bib0210","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1200\/JCO.2015.64.2702","article-title":"Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3","volume":"34","author":"Scher","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931119300690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931119300690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:57Z","timestamp":1762876017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931119300690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2588931119300690"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2019.05.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study\/SPCG11","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}